BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/20/2023 7:26:29 AM | Browse: 136 | Download: 219
 |
Received |
|
2022-09-28 00:22 |
|
Peer-Review Started |
|
2022-09-28 00:24 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-01-04 16:23 |
|
Revised |
|
2023-02-05 14:20 |
|
Second Decision |
|
2023-03-20 03:15 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2023-03-20 09:21 |
|
Articles in Press |
|
2023-03-20 09:21 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-03-21 06:03 |
|
Publish the Manuscript Online |
|
2023-04-20 07:26 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
COVID-19 and liver injury: Pathophysiology, risk factors, outcome and management in special populations
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Romina Roshanshad, Amirhossein Roshanshad, Reza Fereidooni and Mahnaz Hosseini-Bensenjan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Amirhossein Roshanshad, MD, Postdoctoral Fellow, Research Fellow, Department of MPH, Shiraz University of Medical Sciences, Zand Street, Shiraz 7184731443, Iran. aroshanshad@gmail.com |
| Key Words |
SARS-CoV-2; COVID-19; Liver injury; Chronic liver disease; Management; Liver transplant |
| Core Tip |
Severe acute respiratory syndrome coronavirus-2 can involve the liver and cause damage through different mechanisms. Liver injury can be diagnosed based on alterations in the liver function tests, which can also predict the disease severity and fatality. In patients without underlying liver disease, liver injury is typically mild and can be treated with supportive care. However, it requires additional awareness and appropriate therapy in patients with chronic liver diseases, including autoimmune hepatitis, viral hepatitis, liver cirrhosis, liver transplantation, and nonalcoholic fatty liver disease, which we have discussed in detail. |
| Publish Date |
2023-04-20 07:26 |
| Citation |
Roshanshad R, Roshanshad A, Fereidooni R, Hosseini-Bensenjan M. COVID-19 and liver injury: Pathophysiology, risk factors, outcome and management in special populations. World J Hepatol 2023; 15(4): 441-459 |
| URL |
https://www.wjgnet.com/1948-5182/full/v15/i4/441.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v15.i4.441 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
